SYRA Syra Health Corporation: Forward P/S Multiple
Syra Health Corp. (SYRA) operates entirely within the US, leaving its business fully insulated from external geopolitical risks and sanctions. The expected P/S ratio reflects market valuation trends, with the current parameter standing at 0.10. While the company generates revenue through IT contracts with the public sector and schools, it faces stringent HIPAA compliance requirements and significant regulatory barriers when deploying its digital products.
Comprehensive metric breakdowns and analytics for Syra Health, Corp. (SYRA)
- current price and projected stock value:
- company stock capitalization data:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Syra Health Corp.|SYRA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Syra Health Corp.|SYRA - Aggregate Debt Obligations|Debts to Book Capitalization Syra Health, Corp.|SYRA - Company Long-Term Liabilities|Company Short-Term Debt Syra Health|Quick Liquidity syrahealth.com
- business earnings and investment ratios data:
SYRA - Final Profit|Expected Profit Syra Health Corp.|SYRA - Market Cap to Net Income|Projected Price to Earnings Syra Health Corporation|SYRA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Syra Health, Corp.|SYRA - Operating income before deduction of amortization|Net earnings per share for the last 12 months Syra Health|SYRA - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months syrahealth.com|SYRA - Earnings per share increase in current year|Earnings growth forecast for next year Syra Health Corp.
- sales revenue and business income indicators:
Summary company analysis:Syra Health SYRA
The forward P/S ratio trend reflects the scaling efficiency of Syra Health Corp. (SYRA) digital medical data logistics, where cloud-based supply chain optimization directly impacts revenue growth rates. This indicator benchmarks current market capitalization against projected sales, allowing investors to assess the fairness of the market value relative to expected margins and identify potential asset overvaluation risks.
Competitors of Syra Health Corp. (SYRA)
Forward P/S Multiple VEEV (Veeva)|Doximity Inc (DOCS) - Market Cap to Future Revenue Ratio|HealthEquity Corp - Forward P/S Multiple|WAY - Forward P/S Multiple|CorVel Corporation (CRVL) - Price-to-Projected Revenue Ratio|PRVA (priviahealth.com) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple HURN|CERT (Certara Inc) - Price to Expected Revenue Ratio|Forward P/S Multiple OMCL|GDRX (GoodRx Gold) - Forward Price to Sales|Schrodinger, Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales PHR|Omada Health - Forward P/S Multiple|Evolent Health Inc (EVH) - Forward Price-to-Revenue Multiple|HealthStream Corp (HSTM) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Definitive Corp (DH)|Price-to-Projected Revenue Ratio Consensus Cloud Solutions|AGL: Forward Price to Sales|Price-to-Projected Revenue Ratio Absci Corporation (ABSI)|SY: Future Price to Revenue|National Research Corporation - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio USA Mobility (SPOK)|OPRX - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio trubridge.com TBRG|SLP (Simulations Plus) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio SOPHiA GENETICS (SOPH)|Price-to-Projected Revenue Ratio Health Catalyst, Inc|CCLD: Forward Price to Sales|Forward P/S Multiple RSSS|Forward P/S Multiple dlhcorp.com (DLHC)|Forward P/S Multiple ONMD (OneMedNet)|Market Cap to Expected Sales Ratio Scienture Holdings (SCNX)|HCTI: Forward Price-to-Revenue Multiple|iSpecimen Inc. - Price to Expected Revenue Ratio|BFRG (bullfrogai.com) - Forward Price-to-Revenue Multiple|scworx.com - Forward Price to Sales|Price-to-Projected Revenue Ratio MSP Recovery|Forward Price-to-Revenue Multiple iCoreConnect Corp (ICCT)|Forward P/S Multiple MEDS|ORGS - Market Cap to Future Revenue Ratio|Forward P/S Multiple RCM (R1 RCM)|SHCR: Market Cap to Projected Revenue|STRM - Price-to-Projected Revenue Ratio|Market Cap to Expected Sales Ratio Apollo Medical Holdings AMEH|MODN (Model N Corp) - Forward Price-to-Revenue Multiple|Market Cap to Future Revenue Ratio NextGen Healthcare Corp (NXGN)
